Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACB/PAI/IPACK vs PAI for Pain After Total Knee Arthroplasty
NCT03094663Phase 4Completed
- Sponsor
- Hospital for Special Surgery
- Start
- Feb 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Hospital for Special Surgery. Started Feb 2017; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03094663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03094663.